Authors
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Challenges, Opportunities Mark Health Care Landscape in 2022Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend
Latest:
Impact of HIE Drug Formularies on Patient Out-of-Pocket CostsBenefit structure and formulary design characteristics are important for individuals with high out-of-pocket costs in federally facilitated Health Insurance Exchanges.
Latest:
GlaxoSmithKline and Human Genome Sciences, Inc's BenlystaThs FDA approved Benlysta (belimumab) for the treatment of adults with active, autoantibody- positive systemic lupus.
Latest:
Bring Your Own Weather: How Your Attitude Affects OthersHow much do your actions affect those around you? Read here to learn about how to consciously change your environment.
Latest:
Opioid Overdose and Naloxone Delivery Devices in the Community SettingAlthough naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Latest:
Practice Pearl: Envisioning Your FutureAn evolving pharmacy practice started with the the owners' vision, and worked backwards to become a reality.
Latest:
Historic Trends Provide Context to 2016 NAPLEX and MPJE Performance DataEnsuring that the North American Pharmacist Licensure Examination and the Multistate Pharmacy Jurisprudence Examination accurately measure the competence of candidates seeking licensure is of the utmost importance to the boards of pharmacy and the National Association of Boards of Pharmacy.
Latest:
USP Workshop Examines Ways to Improve Medicines Quality in Asia-Pacific RegionThe U.S. Pharmacopeial Convention (USP) is bringing together national medicines control laboratory officials, as part of ongoing efforts to strengthen regional cooperation for improved medicines quality in the Asia-Pacific region.
Latest:
Will Biosimilars be the Future of Specialty Pharmacy?Biosimilars present a cost-saving opportunity for the health care system, but significant challenges inhibit uptake in the US market.
Latest:
Is There an Alternative to PBM Rebates? ICER Paper Examines 3 OptionsWith discussion and debate happening for months in Washington, DC, over drug pricing and the role of pharmacy benefit managers (PBMs), the Institute for Clinical and Economic Review (ICER) published a white paper this week that analyzes 3 possible alternatives to the pharmaceutical rebate system fostered by PBMs.
Latest:
Care Coordination in a New Health Care Model: Improving Outcomes for Patients with DiabetesAvoiding unnecessary utilization of hospitals, improving quality of care, and establishing continuous chronic disease management.
Latest:
Special Specialty Pharmacies: Differentiation from CompetitionRemaining special in the specialty pharmacy space requires innovation.
Latest:
Quality Initiatives: Pharmacists in the ForefrontPharmacists can lead quality transformation within their organizations.
Latest:
Considerations for Specialty Pharmacy as Enforcement on Controlled Substances Ramps Up to Counter Opioid CrisisState regulators and legislatures are considering new requirements for controlled substance prescribing and reporting.
Latest:
Patterns of Specific Testing for Patients With Chronic Myelogenous LeukemiaStudy assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Janssen Pharmaceuticals' XareltoThe FDA approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism following hip or knee replacements and for the prevention of stroke in patients with nonvalvular atrial fibrillation.
Latest:
Your Personal Brand: Education and Experience in Pharmacy InformaticsPharmacy informatics specialists are in high demand.
Latest:
Malignant Hyperthermia, Dantrolene, and the PharmacistMalignant hyperthermia can result in a rare anesthetic emergency and can be fatal.
Latest:
Can Multivitamins Curb Hypertension?Little is known about multivitamin use and associated prevention or development of hypertension, especially in women.
Latest:
Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and OutcomesThis study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.
